Skip to main content
Prasanna Jagannathan, MD, Infectious Disease, Stanford, CA

Prasanna Jagannathan MD


Assistant Professor, Medicine, University of California, San Francisco, School of

Join to View Full Profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Dr. Jagannathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
  • Harvard Medical School
    Harvard Medical SchoolClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria During Pregnancy and Risk of Malaria in Early Childhood: A Randomized Controlled Trial  
    Bryan Greenhouse, Prasanna Jagannathan, Diane V Havlir, PLoS One

Press Mentions

  • Women Are at Much Higher Risk of Long COVID Than Men. Why?
    Women Are at Much Higher Risk of Long COVID Than Men. Why?March 25th, 2025
  • I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?
    I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?September 5th, 2022
  • Paxlovid: Your Questions About the Antiviral COVID-19 Pill Treatment, Answered
    Paxlovid: Your Questions About the Antiviral COVID-19 Pill Treatment, AnsweredJuly 14th, 2022

Grant Support

  • Perennial Malaria Chemoprevention in the Malaria Vaccine Era (PMC-VAC)STANFORD UNIVERSITY2026–2033
  • Innate-adaptive immune bridging in gravidity-dependent immunity against placental malaria: a multi-omics approachSTANFORD UNIVERSITY2025–2030
  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: